Search results
Results from the WOW.Com Content Network
Eli Lilly pleaded guilty to a US federal criminal misdemeanor charge of illegally marketing Zyprexa, actively promoting the drug for off-label uses, particularly for the treatment of dementia in the elderly. [259] The $1.415 billion penalty included an $800 million civil settlement, a $515 million criminal fine, and forfeit assets of $100 ...
Over time, he donated Eli Lilly and Company stock worth a total of $86.8 million to the foundation, including a $30 million bequest following his death in 1948. J. K.'s sons, Eli and Joe, contributed additional Eli Lilly and Company stock that had a combined value of $6.8 million. Eli also managed the foundation in its early years.
Eli Lilly (July 8, 1838 – June 6, 1898) was a Union Army officer, pharmacist, chemist, and businessman who founded Eli Lilly and Company.. Lilly enlisted in the Union Army during the American Civil War and recruited a company of men to serve with him in the 18th Independent Battery Indiana Light Artillery.
For Eli Lilly CEO Dave Ricks, speeding up the drug discovery process is essential to success. ... Ricks: Yeah, well, first of all, if we look at back to our mission, which is to arrest human ...
Eli Lilly (NYSE: LLY) may seem like an expensive stock to invest in right now. Its $720 billion market capitalization also means it's the most valuable healthcare stock in the world. It's one that ...
Josiah Kirby Lilly Sr. (November 18, 1861 – February 8, 1948), nicknamed "J. K.," was an American businessman, pharmaceutical industrialist, and philanthropist who became president and chairman of the board of Eli Lilly and Company, the pharmaceutical firm his father, Colonel Eli Lilly, founded in 1876. Josiah, the colonel's sole heir, began ...
As a major pharmaceutical company that is constantly innovating and developing new treatments, Eli Lilly (NYSE: LLY) is always providing investors with additional reasons to consider buying its stock.
The Plowshares Project was formed in 2002, and is funded by a four-year grant from Eli Lilly and Company. The project defines its mission and goals by the religious ethos of the Church of the Brethren, the Society of Friends, and Mennonite Church USA.